Metabolites
Displaying metabolites 2326 - 2350 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB20298 | TDP-Glucose | {[hydroxy({[3-hydroxy-5-(4-hydroxy-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy}({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | Secondary Metabolites: enterobacterial common antigen biosynthesis 3 PW002046 | 562.3131 C16H24N2O16P2 | |
ECMDB21367 | Uridine 5''-diphospho-{beta}-4-deoxy-4-formamido-L-arabinose | N-[(3S,4S,5R,6R)-6-({[({[(2R,3S,4R)-3,4-dihydroxy-5-(4-oxido-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-4,5-dihydroxyoxan-3-yl]carboximidate | 561.2853 C15H21N3O16P2 | ||
ECMDB01178 | Adenosine diphosphate ribose 20762-30-5 | [({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methoxy})phosphinic acid | 559.3157 C15H23N5O14P2 | ||
ECMDB04137 | Phosphoribosyl-AMP | {[(2R,3S,4R,5R)-5-{1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-6-imino-6,9-dihydro-1H-purin-9-yl}-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid | 559.3157 C15H23N5O14P2 | ||
ECMDB24771 | DG(14:0(3-OH)/16:0/0:0) | (2R)-2-hydroxy-3-[(3-hydroxytetradecanoyl)oxy]propyl hexadecanoate | phospholipid biosynthesis (CL(14:0(3-OH)/16:0/16:0/16:0)) PW001938 | 556.869 C33H64O6 | |
ECMDB24792 | DG(16:0/14:0(3-OH)/0:0) | (2S)-2-hydroxy-3-[(3-hydroxytetradecanoyl)oxy]propyl hexadecanoate | phospholipid biosynthesis (CL(16:0/14:0(3-OH)/16:0/14:0(3-OH))) PW001951 | 556.869 C33H64O6 | |
ECMDB23432 | 3-(all-trans-octaprenyl)benzene-1,2-diol | 3-[(2E,5E,8E,11E,14E,17E,20E)-3,6,9,12,15,18,21,24-octamethylpentacosa-2,5,8,11,14,17,20,23-octaen-1-yl]benzene-1,2-diol | 556.8607 C39H56O2 | ||
ECMDB23440 | PE(10:0(3-OH)/10:0(3-OH)) | (2-aminoethoxy)[(2R)-2,3-bis[(3-hydroxydecanoyl)oxy]propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(10:0/10:0) I PW001743 | 555.639 C25H50NO10P | |
ECMDB24766 | DG(12:0/19:iso/0:0) | 1-(dodecanoyloxy)-3-hydroxypropan-2-yl 17-methyloctadecanoate | phospholipid biosynthesis (CL(12:0/19:iso/12:0/19:iso)) PW001933 | 554.897 C34H66O5 | |
ECMDB24830 | DG(19:iso/12:0/0:0) | 2-(dodecanoyloxy)-3-hydroxypropyl 17-methyloctadecanoate | phospholipid biosynthesis (CL(19:iso/12:0/19:iso/12:0)) PW002001 | 554.897 C34H66O5 | |
ECMDB23272 | DG(15:0/16:0/0:0) | (2S)-2-hydroxy-3-(pentadecanoyloxy)propyl hexadecanoate | phospholipid biosynthesis CDP-DG(15:0/16:0) PW001809 | 554.897 C34H66O5 | |
ECMDB23280 | DG(16:0/15:0/0:0) | (2R)-2-hydroxy-3-(pentadecanoyloxy)propyl hexadecanoate | phospholipid biosynthesis (CDP-DG(16:0/15:0)) PW001745 | 554.897 C34H66O5 | |
ECMDB24759 | DG(12:0(3-OH)/18:1(9Z)/0:0) | (2R)-2-hydroxy-3-[(3-hydroxydodecanoyl)oxy]propyl (9Z)-octadec-9-enoate | phospholipid biosynthesis (CL(12:0(3-OH)/18:1(9Z)/12:0(3-OH)/18:1(9Z))) PW001924 | 554.853 C33H62O6 | |
ECMDB24772 | DG(14:0(3-OH)/16:1(9Z)/0:0) | (2R)-2-hydroxy-3-[(3-hydroxytetradecanoyl)oxy]propyl (9Z)-hexadec-9-enoate | 554.853 C33H62O6 | ||
ECMDB24797 | DG(16:1(9Z)/14:0(3-OH)/0:0) | (2S)-2-hydroxy-3-[(3-hydroxytetradecanoyl)oxy]propyl (9Z)-hexadec-9-enoate | 554.853 C33H62O6 | ||
ECMDB24813 | DG(18:1(9Z)/12:0(3-OH)/0:0) | (2S)-2-hydroxy-3-[(3-hydroxydodecanoyl)oxy]propyl (9Z)-octadec-9-enoate | phospholipid biosynthesis (CL(18:1(9Z)/12:0(3-OH)/18:1(9Z)/12:0(3-OH))) PW001982 | 554.853 C33H62O6 | |
ECMDB24262 | PG(10:0/10:0) | [(2R)-2,3-bis(decanoyloxy)propoxy][(2R)-2,3-dihydroxypropoxy]phosphinic acid | 554.658 C26H51O10P | ||
ECMDB20080 | 3'-Phosphoadenylylselenate | [({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]selenonic acid | 554.16 C10H15N5O13P2Se | ||
ECMDB24777 | DG(14:0/17:0cycw7c/0:0) | (2S)-3-{[8-(2-hexylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl tetradecanoate | phospholipid biosynthesis (CL(19:0cycv8c/17:0cycw7c/14:0/17:0cycw7c)) PW001403 | 552.881 C34H64O5 | |
ECMDB24786 | DG(15:0cyclo/16:0/0:0) | (2R)-3-{[8-(2-butylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl hexadecanoate | phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/16:1(9Z)) PW001096 | 552.881 C34H64O5 | |
ECMDB24793 | DG(16:0/15:0cyclo/0:0) | (2S)-3-{[8-(2-butylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl hexadecanoate | phospholipid biosynthesis CL(16:0/15:0cyclo/16:0/16:0) PW001226 | 552.881 C34H64O5 | |
ECMDB24805 | DG(17:0cycw7c/14:0/0:0) | (2R)-3-{[8-(2-hexylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl tetradecanoate | phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c/14:0) PW001149 | 552.881 C34H64O5 | |
ECMDB23258 | DG(12:0/19:1(9Z)/0:0) | (2S)-3-(dodecanoyloxy)-2-hydroxypropyl (9Z)-nonadec-9-enoate | 552.881 C34H64O5 | ||
ECMDB23273 | DG(15:0/16:1(9Z)/0:0) | (2S)-2-hydroxy-3-(pentadecanoyloxy)propyl (9Z)-hexadec-9-enoate | phospholipid biosynthesis CDP-DG(15:0/16:1(9Z)) PW001810 | 552.881 C34H64O5 | |
ECMDB23289 | DG(16:1(9Z)/15:0/0:0) | (2R)-2-hydroxy-3-(pentadecanoyloxy)propyl (9Z)-hexadec-9-enoate | phospholipid biosynthesis (CDP-DG(16:1(9Z)/15:0)) PW001757 | 552.881 C34H64O5 |